2seventy bio, Inc. (NASDAQ:TSVT) Given Consensus Rating of “Hold” by Analysts
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have been given a consensus recommendation of “Hold” by the seven analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, one has assigned a buy recommendation and […]
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have been given a consensus recommendation of “Hold” by the seven analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, one has assigned a buy recommendation and […]
